PWM
ABBV icon

Proathlete Wealth Management’s AbbVie ABBV Stock Holding History

Proathlete Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$214K Hold
984
– – 0.06% 60
2025
Q4 		$225K Buy
984
+20
+2% +$4.56K 0.06% 61
2025
Q3 		$223K Sell
964
-8
-0.8% -$1.63K 0.06% 60
2025
Q2 		$180K Buy
972
+8
+0.8% +$1.49K 0.06% 61
2025
Q1 		$202K Buy
+964
New +$187K 0.07% 59

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Proathlete Wealth Management's ABBV Position: Q1 2026 in Review

Proathlete Wealth Management held its AbbVie (ABBV) position steady in Q1 2026 at 984 shares worth $214K. The position accounts for 0.06% of the portfolio, ranked #60.

Proathlete Wealth Management first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. The position peaked at $225K in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Proathlete Wealth Management held 984 shares of AbbVie worth $214K as of Q1 2026.
  • Proathlete Wealth Management left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.06% of Proathlete Wealth Management's portfolio in Q1 2026, its #60 holding.
  • Proathlete Wealth Management first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • Proathlete Wealth Management's AbbVie position peaked at $225K in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Proathlete Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.